(Q50864197)

24 March 2018

title

Adiponectin in coronary heart disease and newly diagnosed impaired glucose tolerance (English)

1 reference

24 March 2018

main subject

coronary artery disease

1 reference

Aline Azizi Ghanbari

1

1 reference

24 March 2018

Rolf Dörr

2

1 reference

24 March 2018

Stefan Spitzer

3

1 reference

24 March 2018

Juergen Stumpf

4

1 reference

24 March 2018

Andreas Britz

5

1 reference

24 March 2018

Ildiko Amann-Zalan

6

1 reference

24 March 2018

Volker Lodwig

7

1 reference

24 March 2018

Bernhard Ulm

8

1 reference

24 March 2018

Oliver Schnell

9

1 reference

24 March 2018

Tobias Lohmann

10

1 reference

24 March 2018

language of work or name

English

0 references

publication date

1 July 2013

1 reference

24 March 2018

Diabetes and Vascular Disease Research

published in

1 reference

24 March 2018

volume

10

1 reference

24 March 2018

issue

5

1 reference

24 March 2018

page(s)

452-458

1 reference

24 March 2018

A Novel Serum Protein Similar to C1q, Produced Exclusively in Adipocytes

cites work

1 reference

https://api.crossref.org/works/10.1177%2F1479164113490179

AdipoQ is a novel adipose-specific gene dysregulated in obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479164113490179

cDNA cloning and expression of a novel adipose specific collagen-like factor, apM1 (AdiPose Most abundant Gene transcript 1).

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479164113490179

Adiponectin and protection against type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479164113490179

Novel modulator for endothelial adhesion molecules: adipocyte-derived plasma protein adiponectin

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479164113490179

Plasma adiponectin levels and risk of myocardial infarction in men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479164113490179

Plasma adiponectin, body mass index, and mortality in patients with chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479164113490179

Total and high molecular weight adiponectin, haemodynamics, and mortality in patients with chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479164113490179

Oral glucose tolerance test and HbA1c for diagnosis of diabetes in patients undergoing coronary angiography the Silent Diabetes Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479164113490179

Standards of medical care in diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479164113490179

Assessment of short-, medium-, and long-term variations in arterial dimensions from computer-assisted quantitation of coronary cineangiograms

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479164113490179

Circulating concentrations of the adipocyte protein adiponectin are decreased in parallel with reduced insulin sensitivity during the progression to type 2 diabetes in rhesus monkeys

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479164113490179

Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479164113490179

Adiponectin represents an independent cardiovascular risk factor predicting serum HDL-cholesterol levels in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479164113490179

Adiponectin-mediated modulation of hypertrophic signals in the heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479164113490179

Adiponectin protects against the development of systolic dysfunction following myocardial infarction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479164113490179

Is adiponectin a bystander or a mediator in heart failure? The tangled thread of a good-natured adipokine in aging and cardiovascular disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479164113490179

Natriuretic peptides enhance the production of adiponectin in human adipocytes and in patients with chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479164113490179

Adiponectin and all-cause mortality in elderly people with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479164113490179

Increase in serum adiponectin concentration in patients with heart failure and cachexia: relationship with leptin, other cytokines, and B-type natriuretic peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479164113490179

Adiponectin and its receptors are expressed in adult ventricular cardiomyocytes and upregulated by activation of peroxisome proliferator-activated receptor gamma

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479164113490179

Adiponectin is synthesized and secreted by human and murine cardiomyocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479164113490179

Circulating Adiponectin Levels and Mortality in Elderly Men With and Without Cardiovascular Disease and Heart Failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479164113490179

21 January 2018

Identifiers

DOI

10.1177/1479164113490179

1 reference

24 March 2018

1 reference

24 March 2018